MA49019A - Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation - Google Patents
Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisationInfo
- Publication number
- MA49019A MA49019A MA049019A MA49019A MA49019A MA 49019 A MA49019 A MA 49019A MA 049019 A MA049019 A MA 049019A MA 49019 A MA49019 A MA 49019A MA 49019 A MA49019 A MA 49019A
- Authority
- MA
- Morocco
- Prior art keywords
- new sigma
- receiver modulators
- modulators
- receiver
- sigma
- Prior art date
Links
- 102100037651 AP-2 complex subunit sigma Human genes 0.000 title 1
- 101000806914 Homo sapiens AP-2 complex subunit sigma Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762474277P | 2017-03-21 | 2017-03-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA49019A true MA49019A (fr) | 2020-02-05 |
Family
ID=63585700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA049019A MA49019A (fr) | 2017-03-21 | 2018-03-15 | Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US10961249B2 (enExample) |
| EP (1) | EP3600290B1 (enExample) |
| JP (2) | JP7365237B2 (enExample) |
| MA (1) | MA49019A (enExample) |
| WO (1) | WO2018175188A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014164756A1 (en) | 2013-03-11 | 2014-10-09 | Temple University Of The Commonwealth System Of Higher Education | Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use |
| EP3200589A4 (en) | 2014-09-10 | 2018-07-25 | Temple University Of The Commonwealth System Of Higher Education | Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use |
| EP3541790B1 (en) | 2016-11-15 | 2025-09-03 | Temple University - Of The Commonwealth System of Higher Education | 3-(2-(4-phenylpiperazin-1-yl)ethyl)-2-oxa-8-azaspiro[4.5]decan-1-one derivatives and related compounds as 5-hydroxytryptamine receptor 7 (5-ht7) modulators for treating e.g. inflammatory bowel disease, circadian rhythm disorder or depression |
| WO2018175188A1 (en) * | 2017-03-21 | 2018-09-27 | Temple University-Of The Commonwealth System Of Higher Education | Novel modulators of the sigma-2 receptor and their method of use |
| JP7365238B2 (ja) * | 2017-03-21 | 2023-10-19 | テンプル・ユニバーシティ－オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション | ５－ヒドロキシトリプタミン受容体７調節物質および治療剤としてのその使用 |
| TW202523659A (zh) * | 2018-05-11 | 2025-06-16 | 美國坦普大學 高等教育聯邦系統 | 作為5-羥基色胺受體7之調節劑之新穎官能化內醯胺及其使用方法 |
| GB201809295D0 (en) * | 2018-06-06 | 2018-07-25 | Institute Of Cancer Res Royal Cancer Hospital | Lox inhibitors |
| EP3978497A4 (en) * | 2019-05-30 | 2022-07-13 | Shanghai Institute of Materia Medica, Chinese Academy of Sciences | FUSED CYCLIC COMPOUND, METHOD FOR PREPARING IT AND ITS USE |
| EP4568968A1 (en) * | 2022-08-11 | 2025-06-18 | Remynd N.V. | (aza)spiroheptane derivatives for the treatment of neurodegenerative disorders |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7435830B2 (en) | 2004-03-03 | 2008-10-14 | Chemocentryx, Inc. | Bicyclic and bridged nitrogen heterocycles |
| GB0419192D0 (en) * | 2004-08-27 | 2004-09-29 | Merck Sharp & Dohme | Therapeutic agents |
| EP2081575A4 (en) | 2006-11-13 | 2010-01-06 | King Pharmaceuticals Res & Dev | ALLOSTERIC MODULATORS OF THE A1 ADENOSINE RECEPTOR |
| US8148408B2 (en) | 2008-05-09 | 2012-04-03 | Abbott Laboratories | Selective substituted pyridine ligands for neuronal nicotinic receptors |
| US8697888B2 (en) | 2012-01-06 | 2014-04-15 | Vanderbilt University | Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine M1 receptors |
| WO2014085413A1 (en) | 2012-11-28 | 2014-06-05 | Temple University - Of The Commonwealth System Of Higher Education | Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2b activity modulators |
| SG11201504410PA (en) * | 2012-12-07 | 2015-07-30 | Chemocentryx Inc | Diazole lactams |
| WO2014164756A1 (en) | 2013-03-11 | 2014-10-09 | Temple University Of The Commonwealth System Of Higher Education | Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use |
| WO2014160592A2 (en) | 2013-03-27 | 2014-10-02 | Merck Sharp & Dohme Corp. | FACTOR XIa INHIBITORS |
| KR20160098506A (ko) | 2013-12-20 | 2016-08-18 | 라보라토리오스 델 드라. 에스테브.에스.에이. | 통증에 대한 다양한 활성을 갖는 피페라진 유도체 |
| EP3200589A4 (en) | 2014-09-10 | 2018-07-25 | Temple University Of The Commonwealth System Of Higher Education | Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use |
| EP3204383B1 (en) | 2014-10-08 | 2020-11-18 | F.Hoffmann-La Roche Ag | Spirodiamine derivatives as aldosterone synthase inhibitors |
| TWI770525B (zh) | 2014-12-30 | 2022-07-11 | 美商瓦洛健康公司 | 作為泛素特異性蛋白酶７抑制劑之吡咯并及吡唑并嘧啶 |
| WO2016183150A1 (en) | 2015-05-12 | 2016-11-17 | Temple University-Of The Commonwealth System Of Higher Education | Novel sigma-2 receptor binders and their method of use |
| EP3541790B1 (en) | 2016-11-15 | 2025-09-03 | Temple University - Of The Commonwealth System of Higher Education | 3-(2-(4-phenylpiperazin-1-yl)ethyl)-2-oxa-8-azaspiro[4.5]decan-1-one derivatives and related compounds as 5-hydroxytryptamine receptor 7 (5-ht7) modulators for treating e.g. inflammatory bowel disease, circadian rhythm disorder or depression |
| JP7365238B2 (ja) | 2017-03-21 | 2023-10-19 | テンプル・ユニバーシティ－オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション | ５－ヒドロキシトリプタミン受容体７調節物質および治療剤としてのその使用 |
| WO2018175188A1 (en) | 2017-03-21 | 2018-09-27 | Temple University-Of The Commonwealth System Of Higher Education | Novel modulators of the sigma-2 receptor and their method of use |
| TW202523659A (zh) | 2018-05-11 | 2025-06-16 | 美國坦普大學 高等教育聯邦系統 | 作為5-羥基色胺受體7之調節劑之新穎官能化內醯胺及其使用方法 |
| BR112022009361A2 (pt) | 2019-11-13 | 2022-08-09 | Univ Temple | Novas lactonas funcionalizadas como moduladores do receptor 7 de 5- hidroxitriptamina e seu método de uso |
| CN115003675A (zh) | 2019-11-13 | 2022-09-02 | 英联邦高等教育系统坦普尔大学 | 作为5-羟色胺受体7调节剂的新型官能化内酰胺及其使用方法 |
-
2018
- 2018-03-15 WO PCT/US2018/022574 patent/WO2018175188A1/en not_active Ceased
- 2018-03-15 US US16/496,073 patent/US10961249B2/en active Active
- 2018-03-15 MA MA049019A patent/MA49019A/fr unknown
- 2018-03-15 JP JP2019551998A patent/JP7365237B2/ja active Active
- 2018-03-15 EP EP18772377.0A patent/EP3600290B1/en active Active
-
2021
- 2021-01-21 US US17/154,761 patent/US11820774B2/en active Active
-
2023
- 2023-10-06 JP JP2023174368A patent/JP7781122B2/ja active Active
- 2023-10-11 US US18/484,858 patent/US20240300954A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240300954A1 (en) | 2024-09-12 |
| EP3600290A4 (en) | 2020-08-12 |
| JP2023168623A (ja) | 2023-11-24 |
| US20200039985A1 (en) | 2020-02-06 |
| US10961249B2 (en) | 2021-03-30 |
| JP7365237B2 (ja) | 2023-10-19 |
| JP2020511506A (ja) | 2020-04-16 |
| US20210363145A1 (en) | 2021-11-25 |
| EP3600290C0 (en) | 2025-06-04 |
| JP7781122B2 (ja) | 2025-12-05 |
| EP3600290A1 (en) | 2020-02-05 |
| WO2018175188A1 (en) | 2018-09-27 |
| US11820774B2 (en) | 2023-11-21 |
| EP3600290B1 (en) | 2025-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA49019A (fr) | Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation | |
| EP3310305A4 (en) | BRANCHED AORTIC TRANSPLANT AND METHOD OF USE THEREOF | |
| EP3541790A4 (en) | NEW MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD FOR USE THEREOF | |
| EP3303634A4 (en) | CAS9 VARIANTS AND METHOD FOR USE THEREOF | |
| EP3368404A4 (en) | SEPARATE TOWER JOINT ARRANGEMENT AND METHOD FOR USE THEREOF | |
| EP3385835A4 (en) | METHOD AND DEVICE FOR CONFIGURING A ACCELERATOR | |
| EP3394065A4 (en) | TETRAHYDROPYRANYL-AMINO-PYRROLOPYRIMIDINONE AND METHOD OF USE THEREOF | |
| MA43385A (fr) | Nouveaux anticorps anti-claudine et méthodes d'utilisation | |
| EP3119761C0 (en) | ANTI-AMYLOID AGENTS AND METHODS OF USE THEREOF | |
| EP3371930A4 (en) | METHOD AND DEVICE FOR SECURE AGGREGATED EVENT MESSAGE | |
| EP3303435A4 (en) | HYDROFLUOROLEFINES AND METHOD OF USE THEREOF | |
| EP3816282A4 (en) | LUCIFERIN BIOSYNTHETIC ENZYMES AND THEIR USE | |
| EP3638037A4 (en) | INSECTICIDAL PROTEINS FROM PLANTS AND METHOD OF USING THEM | |
| MA43282A (fr) | Nouveaux anticorps anti-emr2 et méthodes d'utilisation associées | |
| EP3604367A4 (en) | BLOCK CO-POLYMER AND METHOD FOR MANUFACTURING A BLOCK CO-POLYMER | |
| EP3632933A4 (en) | Novel anti-cd40 antibodies and use thereof | |
| EP3101933A4 (en) | PHYSICAL CELL IDENTIFIER ASSIGNMENT METHOD AND DEVICE | |
| EP3490993C0 (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| EP3411046A4 (en) | RAPAGLUTINES, NOVEL GLUT INHIBITORS AND USES THEREOF | |
| EP3386217A4 (en) | AUDIO REPRODUCTION METHOD AND DEVICE THEREFOR | |
| MA44087A (fr) | Immunothérapie basée sur la listéria et ses méthodes d'utilisation | |
| EP3528631A4 (en) | PLANT INSECTICIDE PROTEINS AND METHOD FOR USE THEREOF | |
| EP3334522A4 (en) | ADSORPTION AGENTS AND METHOD FOR THE PRODUCTION AND USE OF ADSORPTION AGENTS | |
| PL3509064T3 (pl) | Urządzenie odbiorcze strumieni audio i sposób | |
| EP3297573A4 (en) | STENT AND METHOD OF USE |